|
1
|
Parenteral influenza vaccination induces a rapid systemic and local immune response.
|
J Infect Dis
|
1995
|
2.67
|
|
2
|
An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination.
|
Vaccine
|
1994
|
2.09
|
|
3
|
The next influenza pandemic: lessons from Hong Kong, 1997.
|
Emerg Infect Dis
|
1999
|
1.58
|
|
4
|
Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice.
|
Scand J Immunol
|
2005
|
1.28
|
|
5
|
Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination.
|
J Infect Dis
|
1998
|
1.24
|
|
6
|
Staphylococcus aureus exopolysaccharide in vivo demonstrated by immunomagnetic separation and electron microscopy.
|
J Clin Microbiol
|
1989
|
1.10
|
|
7
|
Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunization or natural infection.
|
J Hyg (Lond)
|
1981
|
1.09
|
|
8
|
Antibodies to staphylococcal peptidoglycan and its peptide epitopes, teichoic acid, and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections.
|
J Clin Microbiol
|
1989
|
1.02
|
|
9
|
Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 viruses. Antiviral activities of the antibodies in biological systems.
|
Acta Pathol Microbiol Scand B
|
1980
|
0.98
|
|
10
|
Antigenic variants of influenza A virus obtained in vitro.
|
Bull World Health Organ
|
1976
|
0.98
|
|
11
|
Cross-reaction but no avidity change of the serum antibody response after influenza vaccination.
|
Vaccine
|
1995
|
0.96
|
|
12
|
A monoclonal antibody inhibiting human placental Fc gamma-receptor activity.
|
Int Arch Allergy Appl Immunol
|
1984
|
0.95
|
|
13
|
Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication.
|
Scand J Immunol
|
2002
|
0.94
|
|
14
|
A comparison of the humoral and cellular immune responses at different immunological sites after split influenza virus vaccination of mice.
|
Scand J Immunol
|
2007
|
0.93
|
|
15
|
Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals.
|
Clin Exp Immunol
|
1996
|
0.92
|
|
16
|
The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination.
|
J Infect Dis
|
1999
|
0.92
|
|
17
|
Impact of influenza vaccine formulation with a detailed analysis of the cytokine response.
|
Scand J Immunol
|
2006
|
0.91
|
|
18
|
Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice.
|
Scand J Immunol
|
2005
|
0.90
|
|
19
|
Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant.
|
Dev Biol Stand
|
1998
|
0.88
|
|
20
|
Systemic and local immune responses after parenteral influenza vaccination in juvenile diabetic patients and healthy controls: results from a pilot study.
|
Vaccine
|
1998
|
0.87
|
|
21
|
Haemagglutination-inhibition antibodies in human sera to an antigenic mutant of influenza A/Texas/1/77 (H3N2) virus obtained in vitro.
|
Acta Pathol Microbiol Scand B
|
1980
|
0.86
|
|
22
|
IgA, IgA subclasses, and secretory component levels in oral fluid collected from subjects after parental influenza vaccination.
|
J Infect Dis
|
1995
|
0.85
|
|
23
|
Single-radial-complement-fixation: a new immunodiffusion technique. Assay of the antibody response to the type-specific antigens of influenza virus in post-infection human sera.
|
Bull World Health Organ
|
1978
|
0.83
|
|
24
|
The effect of zanamivir treatment on the early immune response to influenza vaccination.
|
Vaccine
|
2001
|
0.81
|
|
25
|
Surveillance of the antibody status to current influenza strains in the Norwegian population. 2: Antibodies to the A/USSR/90/77 (H1N1) virus in various age groups after the second epidemic wave.
|
NIPH Ann
|
1980
|
0.79
|
|
26
|
Monoclonal antibodies evoked by the free oligopeptide (Gly)5 reacting specifically with peptidoglycan from staphylococci.
|
J Immunol Methods
|
1987
|
0.79
|
|
27
|
Monoclonal antibodies to the h1 agglutinogen from Staphylococcus aureus 17A. Serological testing with type strains.
|
Acta Pathol Microbiol Immunol Scand B
|
1984
|
0.78
|
|
28
|
The immunogenicity of a cell-derived H7N1 split influenza virion vaccine in mice.
|
Scand J Immunol
|
2009
|
0.77
|
|
29
|
Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients.
|
Acta Neurol Scand
|
1994
|
0.77
|
|
30
|
Recommendations of the 7th European Meeting of Influenza and Its Prevention.
|
Eur J Epidemiol
|
1994
|
0.76
|
|
31
|
Antibodies to lipoteichoic acid from Staphylococcus aureus. Specificity of murine monoclonal and human antibodies.
|
Acta Pathol Microbiol Immunol Scand C
|
1985
|
0.75
|
|
32
|
Reactivity of rabbit IgG-fragments in single-radial-immunodiffusion.
|
Acta Pathol Microbiol Scand B
|
1976
|
0.75
|
|
33
|
Intrathecal synthesis of antibodies to staphylococcal antigens in multiple sclerosis patients.
|
Acta Pathol Microbiol Immunol Scand C
|
1986
|
0.75
|
|
34
|
[Influenza strategy].
|
Tidsskr Nor Laegeforen
|
1978
|
0.75
|
|
35
|
Surveillance of the antibody status to current influenza strains in the Norwegian population. 1: Method of serum sampling and evaluation of the A/USSR/77 (H1N1) impact in various age groups in 1978.
|
NIPH Ann
|
1979
|
0.75
|
|
36
|
Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 viruses. 1. Preparation of antibodies and in vitro studies.
|
Acta Pathol Microbiol Scand B
|
1979
|
0.75
|
|
37
|
Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 virus. 3. Selection of antigenic variations in vitro and in vivo.
|
Acta Pathol Microbiol Scand B
|
1980
|
0.75
|
|
38
|
[Use of influenza vaccine in Norway].
|
Tidsskr Nor Laegeforen
|
1996
|
0.75
|